- Home
- RYTM vs EXLS Comparison
RYTM vs EXLS Comparison
Compare RYTM & EXLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYTM
- EXLS
- Stock Information
- Founded
- RYTM 2008
- EXLS 1999
- Country
- RYTM United States
- EXLS United States
- Employees
- RYTM N/A
- EXLS 59500
- Industry
- RYTM Biotechnology: Pharmaceutical Preparations
- EXLS Business Services
- Sector
- RYTM Health Care
- EXLS Consumer Discretionary
- Exchange
- RYTM Nasdaq
- EXLS Nasdaq
- Market Cap
- RYTM 5.9B
- EXLS 6.9B
- IPO Year
- RYTM 2017
- EXLS 2006
- Fundamental
- Price
- RYTM $97.61
- EXLS $42.34
- Analyst Decision
- RYTM Strong Buy
- EXLS Strong Buy
- Analyst Count
- RYTM 13
- EXLS 6
- Target Price
- RYTM $101.92
- EXLS $51.50
- AVG Volume (30 Days)
- RYTM 578.8K
- EXLS 1.8M
- Earning Date
- RYTM 08-05-2025
- EXLS 07-29-2025
- Dividend Yield
- RYTM N/A
- EXLS N/A
- EPS Growth
- RYTM N/A
- EXLS 34.45
- EPS
- RYTM N/A
- EXLS 1.45
- Revenue
- RYTM $156,287,000.00
- EXLS $1,968,978,000.00
- Revenue This Year
- RYTM $37.86
- EXLS $14.23
- Revenue Next Year
- RYTM $72.72
- EXLS $11.43
- P/E Ratio
- RYTM N/A
- EXLS $29.18
- Revenue Growth
- RYTM 53.55
- EXLS 15.15
- 52 Week Low
- RYTM $43.57
- EXLS $35.00
- 52 Week High
- RYTM $99.04
- EXLS $52.43
- Technical
- Relative Strength Index (RSI)
- RYTM 73.48
- EXLS 45.19
- Support Level
- RYTM $95.30
- EXLS $41.93
- Resistance Level
- RYTM $99.04
- EXLS $43.24
- Average True Range (ATR)
- RYTM 3.21
- EXLS 1.10
- MACD
- RYTM 0.20
- EXLS 0.12
- Stochastic Oscillator
- RYTM 90.50
- EXLS 8.45
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
About EXLS ExlService Holdings Inc.
ExlService Holdings Inc. is a business process management company that provides digital operations and analytical services to clients driving enterprise-scale business transformation initiatives that leverage the company's deep expertise in analytics, AI, ML, and cloud. The company offers business process outsourcing and automation services, and data-driven insights to customers across multiple industries. The company operates through four segments based on the products and services offered and markets served: Insurance, Healthcare, Emerging Business, and Analytics . The vast majority of the company's revenue is earned in the United States, and more than half of its revenue comes from Analytics segment.